Atomistry » Fluorine » PDB 1o5g-1q6m » 1pxl
Atomistry »
  Fluorine »
    PDB 1o5g-1q6m »
      1pxl »

Fluorine in PDB 1pxl: Human Cyclin Dependent Kinase 2 Complexed with the Inhibitor [4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]- (4-Trifluoromethyl-Phenyl)-Amine

Protein crystallography data

The structure of Human Cyclin Dependent Kinase 2 Complexed with the Inhibitor [4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]- (4-Trifluoromethyl-Phenyl)-Amine, PDB code: 1pxl was solved by S.Y.Wu, I.Mcnae, G.Kontopidis, S.J.Mcclue, C.Mcinnes, K.J.Stewart, S.Wang, D.I.Zheleva, H.Marriage, D.P.Lane, P.Taylor, P.M.Fischer, M.D.Walkinshaw, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 16.47 / 2.50
Space group P 21 21 21
Cell size a, b, c (Å), α, β, γ (°) 52.709, 71.575, 70.429, 90.00, 90.00, 90.00
R / Rfree (%) 20.4 / 24.9

Fluorine Binding Sites:

The binding sites of Fluorine atom in the Human Cyclin Dependent Kinase 2 Complexed with the Inhibitor [4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]- (4-Trifluoromethyl-Phenyl)-Amine (pdb code 1pxl). This binding sites where shown within 5.0 Angstroms radius around Fluorine atom.
In total 3 binding sites of Fluorine where determined in the Human Cyclin Dependent Kinase 2 Complexed with the Inhibitor [4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]- (4-Trifluoromethyl-Phenyl)-Amine, PDB code: 1pxl:
Jump to Fluorine binding site number: 1; 2; 3;

Fluorine binding site 1 out of 3 in 1pxl

Go back to Fluorine Binding Sites List in 1pxl
Fluorine binding site 1 out of 3 in the Human Cyclin Dependent Kinase 2 Complexed with the Inhibitor [4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]- (4-Trifluoromethyl-Phenyl)-Amine


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 1 of Human Cyclin Dependent Kinase 2 Complexed with the Inhibitor [4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]- (4-Trifluoromethyl-Phenyl)-Amine within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F500

b:58.9
occ:0.59
F8B A:CK4500 0.0 58.9 0.6
C7B A:CK4500 1.4 58.1 0.6
F1B A:CK4500 2.3 58.1 0.6
F9B A:CK4500 2.3 58.6 0.6
C4B A:CK4500 2.4 56.1 0.6
C3B A:CK4500 2.9 55.9 0.6
O A:ILE10 3.5 78.3 1.0
C5B A:CK4500 3.7 55.6 0.6
OD2 A:ASP86 4.1 37.4 1.0
C2B A:CK4500 4.3 54.9 0.6
CE A:LYS89 4.4 64.6 1.0
C A:ILE10 4.7 77.3 1.0
C6B A:CK4500 4.8 54.4 0.6
CG A:ASP86 5.0 36.7 1.0

Fluorine binding site 2 out of 3 in 1pxl

Go back to Fluorine Binding Sites List in 1pxl
Fluorine binding site 2 out of 3 in the Human Cyclin Dependent Kinase 2 Complexed with the Inhibitor [4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]- (4-Trifluoromethyl-Phenyl)-Amine


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 2 of Human Cyclin Dependent Kinase 2 Complexed with the Inhibitor [4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]- (4-Trifluoromethyl-Phenyl)-Amine within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F500

b:58.1
occ:0.59
F1B A:CK4500 0.0 58.1 0.6
C7B A:CK4500 1.4 58.1 0.6
F8B A:CK4500 2.3 58.9 0.6
F9B A:CK4500 2.3 58.6 0.6
C4B A:CK4500 2.5 56.1 0.6
C5B A:CK4500 2.9 55.6 0.6
C3B A:CK4500 3.8 55.9 0.6
CE A:LYS89 3.9 64.6 1.0
CG A:LYS89 4.2 54.3 1.0
C6B A:CK4500 4.3 54.4 0.6
CD A:LYS89 4.4 62.0 1.0
O A:HOH532 4.5 43.3 1.0
CB A:LYS89 4.7 49.4 1.0
NZ A:LYS89 4.9 66.4 1.0
C2B A:CK4500 5.0 54.9 0.6

Fluorine binding site 3 out of 3 in 1pxl

Go back to Fluorine Binding Sites List in 1pxl
Fluorine binding site 3 out of 3 in the Human Cyclin Dependent Kinase 2 Complexed with the Inhibitor [4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]- (4-Trifluoromethyl-Phenyl)-Amine


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 3 of Human Cyclin Dependent Kinase 2 Complexed with the Inhibitor [4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]- (4-Trifluoromethyl-Phenyl)-Amine within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F500

b:58.6
occ:0.59
F9B A:CK4500 0.0 58.6 0.6
C7B A:CK4500 1.4 58.1 0.6
F8B A:CK4500 2.3 58.9 0.6
F1B A:CK4500 2.3 58.1 0.6
C4B A:CK4500 2.5 56.1 0.6
OD2 A:ASP86 3.0 37.4 1.0
CE A:LYS89 3.1 64.6 1.0
C3B A:CK4500 3.3 55.9 0.6
CB A:LYS89 3.3 49.4 1.0
OD1 A:ASP86 3.4 36.0 1.0
CG A:ASP86 3.4 36.7 1.0
C5B A:CK4500 3.4 55.6 0.6
CG A:LYS89 3.5 54.3 1.0
CD A:LYS89 3.9 62.0 1.0
NZ A:LYS89 4.2 66.4 1.0
CA A:LYS89 4.5 45.7 1.0
C2B A:CK4500 4.5 54.9 0.6
N A:ASP86 4.6 36.9 1.0
C6B A:CK4500 4.7 54.4 0.6
CB A:ASP86 4.7 37.1 1.0
N A:LYS89 4.8 45.7 1.0

Reference:

S.Y.Wu, I.Mcnae, G.Kontopidis, S.J.Mcclue, C.Mcinnes, K.J.Stewart, S.Wang, D.I.Zheleva, H.Marriage, D.P.Lane, P.Taylor, P.M.Fischer, M.D.Walkinshaw. Discovery of A Novel Family of Cdk Inhibitors with the Program Lidaeus: Structural Basis For Ligand-Induced Disordering of the Activation Loop Structure V. 11 399 2003.
ISSN: ISSN 0969-2126
PubMed: 12679018
DOI: 10.1016/S0969-2126(03)00060-1
Page generated: Wed Jul 31 12:22:27 2024

Last articles

Zn in 9JPJ
Zn in 9JP7
Zn in 9JPK
Zn in 9JPL
Zn in 9GN6
Zn in 9GN7
Zn in 9GKU
Zn in 9GKW
Zn in 9GKX
Zn in 9GL0
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy